Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201280
Max Phase: Preclinical
Molecular Formula: C31H48N2O8
Molecular Weight: 576.73
Associated Items:
ID: ALA5201280
Max Phase: Preclinical
Molecular Formula: C31H48N2O8
Molecular Weight: 576.73
Associated Items:
Canonical SMILES: CO[C@@H]1C[C@@]2(CO2)[C@H](O)[C@@H](/C=C/C(C)=C/C[C@@H]2O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(=O)N3CCCCC3)C[C@@H]2C)O1
Standard InChI: InChI=1S/C31H48N2O8/c1-20(10-13-26-29(35)31(19-38-31)18-28(37-5)41-26)9-12-25-21(2)17-24(23(4)40-25)32-27(34)14-11-22(3)39-30(36)33-15-7-6-8-16-33/h9-11,13-14,21-26,28-29,35H,6-8,12,15-19H2,1-5H3,(H,32,34)/b13-10+,14-11-,20-9+/t21-,22-,23+,24+,25-,26+,28-,29+,31+/m0/s1
Standard InChI Key: QVARHCCVCHWNOD-RQFNMGTPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 576.73 | Molecular Weight (Monoisotopic): 576.3411 | AlogP: 3.64 | #Rotatable Bonds: 9 |
Polar Surface Area: 119.09 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.91 | CX Basic pKa: | CX LogP: 3.25 | CX LogD: 3.25 |
Aromatic Rings: 0 | Heavy Atoms: 41 | QED Weighted: 0.24 | Np Likeness Score: 1.99 |
1. Ghosh AK, Mishevich JL, Jurica MS.. (2021) Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors., 84 (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100] |
Source(1):